10 years after its identification, the tumour suppressor phosphatase and tensin homologue (PTEN) still holds lots of surprises. Three studies, published in Cell, provide insights into how ubiquitylation regulates PTEN stability and its nuclear localization, as well as the role of nuclear PTEN in chromosomal integrity.

PTEN is a plasma-membrane lipid phosphatase that antagonizes the function of the phosphatidylinositol 3-kinase (PI3K)–AKT/protein kinase B (PKB) pathway. Various mutations in PTEN have been associated with primary tumours, and an inherited PTEN mutation causes Cowden syndrome — patients with this mutation have an increased risk of tumour development. Although this protein has been extensively studied, there are some unresolved questions. For example, some PTEN mutations occur in regions other than the phosphatase domain, which indicates that PTEN might have other functions in addition to the regulation of PI3K signalling. Intriguingly, this plasma-membrane phosphatase has also been found in cell nuclei, so what is the mechanism and function of this nuclear translocation?

Wang et al. showed that PTEN is ubiquitylated in vitro and in vivo, and purified its ubiquitin ligase as HECT-domain protein NEDD4-1. Although NEDD4-1 alone was not oncogenic, NEDD4-1 overexpression increased the efficiency of Ras-mediated transformation of Trp53-deficient mouse embryonic fibroblasts. Further analysis indicated that the aberrant upregulation of NEDD4-1 can post-translationally suppress PTEN activity in human and mouse cancer samples. The authors propose that NEDD4-1 is a potential proto-oncogene that negatively regulates PTEN through ubiquitylation, a paradigm that is analogous to that of MDM2 and p53.

Trotman et al. investigated a Lys to Glu mutation in PTEN (K289E) that was found in a family with Cowden syndrome. Using an intestinal polyp from a patient with this germline mutation, they showed that although PTEN retains catalytic activity, it fails to accumulate in the nuclei of dysplatic epithelial cells owing to an import defect. Residues Lys289 and Lys13 were identified as important monoubiquitylation sites that are essential for PTEN import. Small-interfering-RNA-mediated depletion of NEDD4-1 caused wild-type PTEN to redistribute in the cytoplasm, whereas the overexpression of NEDD4-1 increased the nuclear localization of PTEN. The authors also showed that polyubiquitylation leads to PTEN degradation in the cytoplasm. By contrast, nuclear monoubiquitylated PTEN is stable and antagonizes the AKT/PKB-mediated survival pathway.

So how does nuclear PTEN affect tumour suppression? Shen et al. found that the disruption of PTEN resulted in an increased number of chromosomal fragments with breakage at the centromeres and chromosomal translocations. PTEN is localized at the centromeres and is physically associated with CENP-C, an integral component of the kinetochore. Furthermore, Pten-null cells exhibited spontaneous DNA double-strand breaks and a decrease in mRNA and protein levels for the Rad51 gene, which is involved in homologous recombination and DNA repair. Chromatin-immunoprecipitation assays revealed that PTEN acts on chromatin and regulates Rad51 expression. Although the exact function of PTEN on the Rad51 gene promoter remains to be clarified, this study shows a fundamental role for PTEN in the maintenance of chromosomal stability through a physical interaction with centromeres and the control of DNA repair. Therefore, PTEN, like p53, might function as a guardian of genomic stability.